ASH/ISTH 2026儿童静脉血栓栓塞症抗凝预防指南
美国血液学会(ASH)与国际血栓与止血学会(ISTH)联合制定儿童VTE抗凝预防循证指南,基于截至2025年4月的系统证据评价,采用GRADE方法形成12条推荐。对实体瘤、创伤或危重患儿条件性建议不预防;对儿童抗磷脂抗体综合征或长期全肠外营养患儿条件性建议预防。
要点
- 实体瘤、创伤、危重患儿条件性不建议抗凝预防。
- 抗磷脂抗体综合征或长期全肠外营养患儿条件性建议抗凝预防。
- 高危数据稀缺,需开展亚组特异性风险评估模型研究。
核心结论
- 高质量儿童VTE抗凝预防数据稀缺,关键研究方向为亚组特异性风险评估模型的开发与验证及风险分层预防策略的评价。
研究设计与样本
- ASH组建多学科指南小组,含1名患者代表;堪萨斯大学卫生系统支持制定过程,包括截至2025年4月的系统证据评价。
- 小组按对临床医生和患者的重要性排序临床问题与结局,采用GRADE方法评估证据确定性并形成推荐。
主要发现
- 专家组就12条推荐达成一致。
- 对实体癌、经历创伤或危重的儿童患者,小组给出条件性推荐建议不进行抗凝预防。
- 对儿童抗磷脂抗体综合征或长期全肠外营养患者,小组给出条件性推荐建议使用抗凝预防。
- 其他涉及亚组包括急性淋巴细胞白血病或淋巴瘤、手术与住院患者及中心静脉通路装置患者。
关键数值与推荐
- 共形成12条推荐;对实体癌、创伤、危重患儿为条件性推荐不抗凝预防。
- 对抗磷脂抗体综合征或长期全肠外营养患儿为条件性推荐抗凝预防。
临床怎么用
- 临床决策应结合患儿所属亚组,按指南条件性推荐权衡是否启动抗凝预防。
- 对实体癌、创伤、危重患儿倾向于不预防;对抗磷脂抗体综合征或长期全肠外营养患儿倾向于预防。
局限性
- 高质量儿童VTE抗凝预防数据稀缺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce. Key research priorities include the development and validation of subgroups-specific VTE risk assessment models, and evaluation of the safety and efficacy of risk-stratified anticoagulant prophylaxis strategies across different pediatric subgroups. BACKGROUND: Venous thromboembolism (VTE) is a significant cause of morbidity in children, particularly among hospitalized patients and those with chronic medical conditions. There is a lack of consensus on anticoagulant prophylaxis strategies. OBJECTIVE: These evidence-based guidelines from the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) are intended to support patients and health care professionals in decisions about anticoagulant prophylaxis for pediatric VTE prevention. METHODS: ASH formed a multidisciplinary guideline panel that included 1 patient representative. The University of Kansas Health System supported the guideline development process, including systematic evidence reviews up to April 2025. Clinical questions and outcomes were prioritized according to their importance for clinicians and patients. The panel used the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach to assess certainty in the evidence and make recommendations. RESULTS: The panel agreed on 12 recommendations. For pediatric patients with solid cancer, who have experienced trauma, or who are critically ill, the panel issued conditional recommendations suggesting no anticoagulant prophylaxis. For pediatric patients with antiphospholipid antibody syndrome, or those on long-term total parenteral nutrition, the panel issued conditional recommendations suggesting the use of anticoagulant prophylaxis. Other pediatric subgroups addressed included patients with acute lymphoblastic leukemia or lymphoma, surgical and hospitalized patients, and those with a central venous access device. CONCLUSIONS: High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce. Key research priorities include the development and validation of subgroups-specific VTE risk assessment models, and evaluation of the safety and efficacy of risk-stratified anticoagulant prophylaxis strategies across different pediatric subgroups.
引用
- Betensky M, Azzam M, Bercovitz R, et al. ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism. Blood Adv. 2026. PMID: 41949461. doi:10.1182/bloodadvances.2025019415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。